Table 1.
Minimum inhibitory concentration (MIC) testing on Nocardia isolate.
| Antimicrobial | MIC (μg/mL) | Range (μg/mL) | Interpretation |
|---|---|---|---|
| Amikacin | ≤1.00 | 1–64 | Susceptible |
| Amoxicillin/clavulanic acid | 32.00 | 2/1–64/32 | Resistant |
| Cefepime | >32.00 | 1–32 | Resistant |
| Cefoxitin | >128.00 | 4–128 | Resistant |
| Ceftriaxone | >64.00 | 4–64 | Resistant |
| Ciprofloxacin | 0.50 | 0.12–4 | Susceptible |
| Clarithromycin | 0.25 | 0.03–16 | Susceptible |
| Doxycycline | 16.00 | 0.12–16 | Resistant |
| Imipenem | >64.00 | 2–64 | Resistant |
| Linezolid | ≤1.00 | 1–32 | Susceptible |
| Minocycline | 8.00 | 1–8 | Resistant |
| Moxifloxacin | ≤0.25 | 0.25–8 | Susceptible |
| Tigecycline | 1.00 | 0.015–4 | No interpretation possiblea |
| Tobramycin | ≤1.00 | 1–16 | Susceptible |
| Trimethoprim/sulfamethoxazole | 2.00 | 0.25/4.75–8/152 | Susceptible |
a
No interpretive criteria (ie, Clinical and Laboratory Standards Institute or drug manufacturer information) available for the interactions between antimicrobial and Nocardia species.